Summary:
Meridien Research is conducting a 52-week clinical trial to determine the effectiveness of an investigational medication compared with placebo in reducing lipid levels in people at high or very high risk of major cardiovascular events who are on a lipid lowering treatment but still have high lipid levels. If you are 18 years of age or older, you may be eligible.
Qualified Participants May Receive:
Study-related evaluations, physical exams, routine lab work, investigational medication, and
compensation of up to $600 for time and travel may be available to those who qualify.